Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Behav Brain Res ; 410: 113368, 2021 07 23.
Artigo em Inglês | MEDLINE | ID: mdl-34000337

RESUMO

The present study investigated hyperalgesia during sickness syndrome in female rats. Hyperalgesia was induced by an intraperitoneal injection of lipopolysaccharide (LPS) or an intracerebroventricular injection of prostaglandin E2 (PGE2). No differences were found in basal mechanical and thermal thresholds or in LPS-induced hyperalgesia in sham-operated animals in the diestrus or proestrus phase or in ovariectomized (OVX) animals. However, higher levels of PGE2 where found in the cerebrospinal fluid of OVX animals compared to sham-operated females. Intracerebroventricular injection of PGE2 produced rapid mechanical hyperalgesia in sham-operated rats while these responses were observed at later times in OVX animals. The protein kinase A (PKA) inhibitor H-89 reduced mechanical PGE2-induced hyperalgesia in OVX female rats, whereas no effect was observed in sham-operated animals. In contrast, the exchange protein activated by cyclic adenosine monophosphate (cAMP; Epac) inhibitor ESI-09 reduced mechanical PGE2-induced hyperalgesia, whereas no effect was observed in OVX animals. PGE2 also induced thermal hyperalgesia in sham-operated and OVX female rats and a similar effect of ESI-09 was observed. These results suggest that PGE2-induced hyperalgesia that is observed during sickness syndrome has different signaling mechanisms in cycling and OVX female rats involving the activation of the cAMP-Epac or cAMP-PKA pathways, respectively.


Assuntos
Proteínas Quinases Dependentes de AMP Cíclico/antagonistas & inibidores , Dinoprostona/farmacologia , Ciclo Estral/efeitos dos fármacos , Fatores de Troca do Nucleotídeo Guanina/antagonistas & inibidores , Hiperalgesia/induzido quimicamente , Hiperalgesia/tratamento farmacológico , Comportamento de Doença/efeitos dos fármacos , Animais , AMP Cíclico/antagonistas & inibidores , Dinoprostona/administração & dosagem , Modelos Animais de Doenças , Feminino , Hidrazonas/farmacologia , Isoquinolinas/farmacologia , Isoxazóis/farmacologia , Lipopolissacarídeos/farmacologia , Ovariectomia , Ratos , Ratos Wistar , Transdução de Sinais/efeitos dos fármacos , Sulfonamidas/farmacologia
2.
Inflammation ; 44(1): 321-333, 2021 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-32875489

RESUMO

Sex differences in the immune response can also affect the febrile response, particularly the fever induced by lipopolysaccharide (LPS). However, other pathogen-associated molecular patterns, such as zymosan A (Zym) and polyinosinic-polycytidylic acid (Poly I:C), also induce fever in male rats with a different time course of cytokine release and different mediators such as endothelin-1 (ET-1). This study investigated whether female sex hormones affect Zym- and Poly I:C-induced fever and the involvement of ET-1 in this response. The fever that was induced by Zym and Poly I:C was higher in ovariectomized (OVX) female rats compared with sham-operated female rats. Estrogen replacement in OVX females reduced Zym- and Poly I:C-induced fever. The ETB receptor antagonist BQ788 reversed the LPS-induced fever in cycling females but not in OVX females. BQ788 did not alter the fever that was induced by Zym or Poly I:C in either cycling or OVX females. These findings suggest that the febrile response in cycling females is lower, independently of the stimulus that is inducing it and is probably controlled by estrogen. Also, ET-1 seems to participate in the febrile response that was induced by LPS in males and cycling females but not in the LPS-induced fever in OVX females. Additionally, ET-1 was not involved in the febrile response that was induced by Zym or Poly I:C in females.


Assuntos
Endotelina-1/metabolismo , Febre/induzido quimicamente , Febre/metabolismo , Hormônios Esteroides Gonadais/metabolismo , Poli I-C/toxicidade , Zimosan/toxicidade , Animais , Endotelina-1/antagonistas & inibidores , Feminino , Injeções Intraventriculares , Masculino , Ovariectomia/tendências , Poli I-C/administração & dosagem , Ratos , Ratos Wistar , Zimosan/administração & dosagem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA